Patient Education and Counseling
Volume 70, Issue 1 , Pages 40-49 , January 2008

Smoking cessation treatment by Dutch respiratory nurses: Reported practice, attitudes and perceived effectiveness

  • D. Kotz

      Affiliations

    • Department of General Practice, School for Public Health and Primary Care (CAPHRI), Maastricht University, The Netherlands
    • Corresponding Author InformationCorresponding author at: Department of General Practice, School for Public Health and Primary Care (CAPHRI), Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. Tel.: +31 43 3882893; fax: +31 43 3619344.
    • ,
  • W. van Litsenburg

      Affiliations

    • Catharina Hospital Eindhoven, The Netherlands
    • Dutch Society of Respiratory Nurses (NVL), Nijkerk, The Netherlands
    • ,
  • R. van Duurling

      Affiliations

    • Department of Respiratory Medicine, Maastricht University Hospital, The Netherlands
    • Dutch Society of Respiratory Nurses (NVL), Nijkerk, The Netherlands
    • ,
  • C.P. van Schayck

      Affiliations

    • Department of General Practice, School for Public Health and Primary Care (CAPHRI), Maastricht University, The Netherlands
    • ,
  • G.J. Wesseling

      Affiliations

    • Department of Respiratory Medicine, Maastricht University Hospital, The Netherlands

Received 3 May 2007 ,Revised 30 August 2007 ,Accepted 1 September 2007.

References 

  1. STIVORO. De L-MIS: stoppen met roken voor longpatiënten. Handleiding voor longverpleegkundigen [The L-MIS: smoking cessation in lung patients. Strategy for respiratory nurses]. STIVORO: Den Haag; 2003.
  2. Kwaliteitsinstituut voor de Gezondheidszorg CBO. Richtlijn Behandeling van Tabaksverslaving [Guideline treating tobacco dependence]. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO; 2004.
  3. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Treating tobacco use and dependence. Clinical practical guideline. Rockville, MD: U.S. Department of Health and Human Services; 2000.
  4. Rice VH, Stead LF, Lancaster T. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2004;
  5. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1 The Lung Health Study. J Am Med Assoc. 1994;272:1497–1505
  6. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276
  7. de Weerdt I, Spapen S. Voorlichting over stoppen met roken door longverpleegkundigen Inventariserend onderzoek naar de mogelijkheden voor toepassing van de L-MIS [Health education for smoking cessation by respiratory nurses. Investigating research on the possibilities to apply the L-MIS]. Haarlem: ResCon, Research & Consultancy; 2000.
  8. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2004;
  9. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2004;
  10. Silagy C. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2004;
  11. Willemsen MC, Wagena EJ, van Schayck CP. De effectiviteit van stoppen-met-rokenmethoden die in Nederland beschikbaar zijn: een systematische review op basis van Cochrane-gegevens [The efficacy of smoking cessation methods available in the Netherlands: a systematic review based on Cochrane data]. Ned Tijdschr Geneeskd. 2003;
  12. Kotz D, Wagena EJ, Wesseling G. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians. Respir Med. 2007;101:568–573
  13. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Brit J Addict. 1991;86:1119–1127
  14. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571
  15. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Brit Med J. 1977;1:1645–1648
  16. Silagy C, Lancaster T, Stead LF, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;
  17. Tonnesen P, Carrozzi L, Fagerstrom KO, Gratziou C, Jimenez-Ruiz C, Nardini S, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy ERS task force guideline. Eur Respir J. 2007;29:390–417
  18. College voor Zorgverzekeringen [Health Care Insurance Board]. Farmacotherapeutisch Kompas. [Pharmacotherapeutical compass]; 2007.
  19. Wagena EJ, Knipschild P, Zeegers MPA. Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. Addiction. 2005;100:317–326
  20. Jimenez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest. 2001;119:1365–1370
  21. Borson S, Claypoole K, McDonald GJ, Depression . Chronic obstructive pulmonary disease: treatment trials. Semin Clin Neuropsychiatry. 1998;3:115–130
  22. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003;65:963–970
  23. Centraal Bureau voor de Statistiek [Statistics Netherlands] (CBS). Gerapporteerde gezondheid en leefstijl; 2006. [Reported health and life style 2006] [cited June 21, 2007].
  24. Kaper J, Wagena EJ, Severens JL, Van Schayck CP. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev. 2005;
  25. Kaper J, Wagena EJ, Willemsen MC, van Schayck CP. Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction. 2005;100:1012–1020
  26. Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management, and prevention of chronic pulmonary disease. Executive summary; 2006 [NHLBI/WHO].

PII: S0738-3991(07)00342-4

doi: 10.1016/j.pec.2007.09.002

Patient Education and Counseling
Volume 70, Issue 1 , Pages 40-49 , January 2008

Article Tools

* Image Usage & Resolution